Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

5.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.3K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient perspectives on ultrasound-guided interventions in respiratory medicine: an international, mixed-methods study.

ERJ open research·2026
Same author

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same author

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same author

International evidence-based recommendations for point-of-care lung ultrasound : 2025 focused update of the 2012 recommendations.

Intensive care medicine·2026
Same author

Progress in lung ultrasound education: An updated systematic review.

The ultrasound journal·2026
Same author

Markers of inflammation and lung function in liver transplant recipients: results from a nationwide cohort study.

Frontiers in immunology·2026

Related Experiment Video

Updated: Feb 15, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

29.1K

[Chronic pulmonary aspergillosis].

Jesper Rømhild Davidsen1, Flemming S Rosenvinge, Kristian Assing

  • 1Jesper.Roemhild.Davidsen@rsyd.dk.

Ugeskrift for Laeger
|February 3, 2018
PubMed
Summary

Chronic pulmonary aspergillosis (CPA) is a serious lung condition often diagnosed late, leading to higher mortality. Early identification of risk factors and prompt diagnosis are crucial for effective treatment and improved patient outcomes.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Medical Mycology

Background:

  • Chronic pulmonary aspergillosis (CPA) is an under-recognized respiratory disease.
  • Delayed diagnosis and treatment of CPA correlate with increased patient mortality.
  • Identifying predisposing factors and at-risk populations is essential for managing CPA.

Purpose of the Study:

  • To highlight the diagnostic challenges in chronic pulmonary aspergillosis.
  • To emphasize the need for a systematic approach in assessing and interpreting CPA findings.
  • To underscore the importance of accurate diagnosis for selecting appropriate antifungal therapy.

Main Methods:

  • Review of diagnostic criteria and clinical presentations of CPA.
  • Analysis of factors influencing diagnostic delays.

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.5K
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

11.1K

Related Experiment Videos

Last Updated: Feb 15, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

29.1K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.5K
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

11.1K
  • Evaluation of treatment selection based on disease classification.
  • Main Results:

    • CPA diagnosis requires careful assessment and interpretation of clinical and mycological data.
    • Systematic evaluation aids in correct disease classification.
    • Targeted antifungal treatment selection depends on accurate diagnosis.

    Conclusions:

    • Improved focus on risk factors and early diagnosis can optimize CPA prognosis.
    • A structured diagnostic approach is fundamental for effective CPA management.
    • Timely and accurate diagnosis guides appropriate antifungal treatment strategies.